What was recalled
This page is a reference document on the FDA Vet-LIRN network rather than a recall event. Vet-LIRN was established under the FDA Center for Veterinary Medicine in 2011 to address a specific surveillance gap: prior to Vet-LIRN, the FDA had limited capacity for rapid multi-state pet food adverse-event investigation. The 2007 Mars Petcare Schwarzengrund Salmonella event (70 human cases / 19 states) and the unfolding 2007-2015 Chinese chicken jerky investigation made clear that pet food adverse events frequently span multiple states and require analytical chemistry, microbiology, and pathology testing capacity beyond what FDA’s in-house laboratories could rapidly deploy.
Vet-LIRN coordinates over 40 state and university veterinary diagnostic laboratories nationwide. Member labs provide their analytical capabilities (Salmonella culture, Listeria culture, mycotoxin assay, heavy metal analysis, pesticide and antibiotic residue testing, pathological histology, viral PCR) to FDA investigations on a coordinated basis. When an emerging pet food event is reported through the FDA Safety Reporting Portal or state veterinary surveillance, Vet-LIRN can rapidly mobilize the closest network labs to begin testing within days. This compresses the investigation timeline from weeks or months (pre-Vet-LIRN) to days or weeks. The framework also produces standardized methodology and result-comparison capability across labs, allowing the FDA to integrate findings into a coherent national surveillance picture.
Why it was recalled
The 2007-2015 Chinese chicken jerky investigation was the operational validation event for Vet-LIRN. Over the 8-year surveillance window, Vet-LIRN coordinated 1,200+ laboratory tests on 250+ products, on-site inspections of Chinese supplier facilities, and a joint CDC case-control study in 2014 (95 cases / 261 controls). Despite extraordinary effort, the investigation never conclusively identified the root cause of the Fanconi-like syndrome illness cluster — but the operational capacity demonstrated by Vet-LIRN became the template for subsequent pet food investigations. Multiple emerging-event responses since 2015 have used Vet-LIRN as the analytical backbone: the 2017-2018 pentobarbital wave (testing rendered tallow samples across Vet-LIRN member labs), the 2019 Hill’s vitamin D event (rapid finished-product testing across multiple states), the 2020-2021 Midwestern aflatoxin events (corn-residue and finished-product mycotoxin testing), and the 2024-2026 H5N1 raw pet food cluster (viral PCR + isolate genetic matching).
Vet-LIRN’s budget is comparatively modest relative to its surveillance scope — under $10M annually as of the 2020s. The network operates as a coordination layer rather than a centralized testing facility; member-lab capacity is donated or reimbursed on a per-test basis. The structure has trade-offs: member labs are not uniformly equipped, and not all states are represented at the same depth. Pet food adverse-event detection in less-represented states relies on FDA contracting with the nearest member lab, which can introduce delay. The framework at the FDA Vet-LIRN page documents the surveillance infrastructure and member lab listing.
Health risks for your pet
Vet-LIRN itself is not a disease event; it is the surveillance infrastructure that detects and characterizes disease events. The cumulative disease toll across Vet-LIRN-investigated events from 2011 to 2026 is substantial: 6,200+ dog illnesses from the Chinese chicken jerky cluster (root cause never identified), 49 CDC-documented human cases from the 2012 Diamond Salmonella event, 130+ dog deaths from the 2020 SportMix aflatoxin event, 25+ dog illnesses from the 2019 Hill’s vitamin D event, multiple cat fatalities from the 2024-2026 H5N1 raw pet food cluster, and ongoing human-disease components in the 2023-2024 Mid America Salmonella outbreak. The Vet-LIRN framework provides the analytical capacity for FDA to investigate each event; the framework’s effectiveness in preventing future events depends on regulatory follow-through (recalls, Warning Letters, enforcement actions) by FDA Center for Veterinary Medicine acting on Vet-LIRN findings.
What to do if you bought affected product
For pet owners: the most actionable use of the Vet-LIRN framework is the FDA Safety Reporting Portal at FDA Safety Reporting Portal — this is the official channel for reporting pet illnesses tied to specific pet food products. Consumer reports through this channel are the upstream input that triggers Vet-LIRN investigation activity. If your pet develops unexplained illness after consuming a specific pet food, document the product brand, manufacturing lot code, purchase location and date, clinical signs and timeline, and any veterinary diagnostic findings; submit through the FDA Safety Reporting Portal. The portal also accepts veterinarian-submitted reports, which can carry more weight given clinical context. The 2007-2015 Chinese chicken jerky cluster surfaced through aggregated consumer reports submitted via this channel.
How this affects KibbleIQ’s grade
Vet-LIRN is regulatory infrastructure, not a recall or controversy attaching to a specific brand. The framework’s relevance to KibbleIQ’s grading is as analytical capacity for future recall-history scoring: under our planned methodology v2, recall-history scoring will rely on the FDA Recalls and Safety Alerts archive and the FDA Outbreaks and Advisories archive — both of which depend on Vet-LIRN for the analytical workload that produces the events listed in those archives. Brands seeking to demonstrate the highest quality posture can include in their public quality programs: (1) participation in the FDA Reportable Food Registry; (2) finished-product testing capacity that aligns with Vet-LIRN methodology; (3) Vet-LIRN-equivalent testing through commercial laboratories on incoming ingredient streams. These are positive quality signals but not currently regulatory or KibbleIQ requirements.